KIO-101

N/A

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameKIO-101
Drug Alias NamePaniDropPaniJectKIO-100 family of compoundsPP-001KIO-101 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitorsInterferon gamma inhibitorsDihydroorotate dehydrogenase inhibitors +[4] 
TargetsDihydroorotate dehydrogenaseInterferon gammaInterleukin-17
Therapy Area/IndicationsUveitisDry Eye SyndromesXerophthalmia +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies4sc Ag
China Registration ClassN/A

Develop Information

Active CompaniesPanoptes Pharma GmbhMedical University Of ViennaLaboratoires Leurquin Mediolanum +[6] 
Inactive CompaniesN/A
Active IndicationsXerophthalmiaKeratoconjunctivitisConjunctival Diseases
Inactive IndicationsUveitisDry Eye SyndromesEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A